INVO Bioscience Inc Stock News
$0.79
5.16%
Nasdaq,
Mon, Dec 30 2024
INVO Bioscience Inc Stock News
Neutral
GlobeNewsWire
●
2 months ago
SARASOTA, Fla. and MIAMI, Oct. 24, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today announced an update regarding its clinic trial plans. The Company received regulatory approval from the Israeli Ministry of Health in July 2024 and s...
Neutral
GlobeNewsWire
●
2 months ago
SARASOTA, Fla. and MIAMI, Oct. 21, 2024 (GLOBE NEWSWIRE) -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility, oncology, and autoimmune diseases through the merger of INVO Biosciences and NAYA Biosciences, today confirmed it has changed its corporate name to NAYA Biosciences Inc. and will begin trading under the ne...
Neutral
GlobeNewsWire
●
3 months ago
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
